Contingency Management in Substance Abuse Treatment

Edited by Stephen T. Higgins, Kenneth Silverman, and Sarah H. Heil
Foreword by Joseph V. Brady

Hardcover
Hardcover
September 26, 2007
ISBN 9781593855710
Price: $59.00
380 Pages
Size: 6" x 9"
order

Sheila M. Alessi, PhD, Department of Psychiatry, University of Connecticut Health Center, Storrs, Connecticut

Leslie Amass, PhD, Schering Plough Global Medical Affairs, Kenilworth, New Jersey

George E. Bigelow, PhD, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland

Alan J. Budney, PhD, Center for Addiction Research, Department of Psychiatry, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas

Kathleen M. Carroll, PhD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut

Dana A. Cavallo, PhD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut

Laura Chivers, MA, Department of Psychology, Harvard University, Cambridge, Massachusetts

Jesse Dallery, PhD, Department of Psychology, University of Florida, Gainesville, Florida

Wendy D. Donlin, PhD, Center for Learning and Health, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland

Charles Drebing, PhD, New England Mental Illness Research Education and Clinical Center, Bedford VA Medical Center, Bedford, Massachusetts

Amy M. Duhig, PhD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut

David H. Epstein, PhD, Clinical Pharmacology and Therapeutics Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland

Sarah H. Heil, PhD, Departments of Psychiatry and Psychology, University of Vermont, Burlington, Vermont

Stephen T. Higgins, PhD, Departments of Psychiatry and Psychology, University of Vermont, Burlington, Vermont

Jonathan B. Kamien, PhD, BioPsych Consulting, Califon, New Jersey

Scott Kellogg, PhD, Department of Psychology, New York University, New York, New York

Todd W. Knealing, PhD, Department of Psychology, Briarcliff University, Sioux City, Iowa

Suchitra Krishnan-Sarin, PhD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut

Richard J. Lamb, PhD, Departments of Psychiatry and Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, Texas

Douglas B. Marlowe, JD, PhD, Treatment Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania

Jesse B. Milby PhD, Department of Psychology, University of Alabama at Birmingham, Birmingham, Alabama

Thomas Newton, MD, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California

Nancy M. Petry, PhD, Department of Psychiatry, University of Connecticut Health Center, Farmington, Connecticut

Kenzie L. Preston, PhD, Clinical Pharmacology and Therapeutics Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland

Richard K. Ries, MD, Department of Psychiatry and Behavioral Sciences, University of Washington, and Harborview Medical Center, Seattle, Washington

Randall E. Rogers, PhD, Substance Abuse Treatment Center, Burlington, Vermont

John M. Roll, PhD, Washington Institute for Mental Illness Research and Training, Washington State University, Spokane, Washington

Marc Rosen, MD, Department of Psychiatry, VA Connecticut Healthcare System, West Haven, Connecticut

Robert Rosenheck, MD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut

Bruce J. Rounsaville, MD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut

Joseph Schumacher, PhD, Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, Alabama

Stacey C. Sigmon, PhD, Department of Psychiatry, University of Vermont, Burlington, Vermont

Kenneth Silverman, PhD, Center for Learning and Health, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland

Catherine Stanger, PhD, Center for Addiction Research, Department of Psychiatry, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas

Maxine L. Stitzer, PhD, Department of Psychiatry and Behavioral Sciences, Behavioral Pharmacology Research Unit, Johns Hopkins Bayview Medical Center, Baltimore, Maryland

Jennifer W. Tidey, PhD, Center for Alcohol and Addiction Studies, and Department of Psychiatry and Human Behavior, Brown University, Providence, Rhode Island

Conrad J. Wong, PhD, Department of Behavioral Science, University of Kentucky College of Medicine, Lexington, Kentucky

Jin H. Yoon, PhD, Department of Psychiatry, University of Vermont, Burlington, Vermont